VirTech Bio
PrivateLast Round
VC Round
Dec 1, 2022
Total Funding Raised
$18.41M
Company Overview
VirTech Bio operates in Healthcare & Life Sciences and is based in Natick, Massachusetts. Its latest recorded funding round was a Seed round in November 2022.
VirTech Bio is a biotechnology company that develops a proprietary hemoglobin-based oxygen carrier (HBOC) solution for applications such as severe blood loss and organ preservation for transplants.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Defense Tech
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VirTech Bio Comparables
Compare VirTech Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HbO2 Therapeutics | 87% | |
| KaloCyte, Inc. | 87% | |
| OxyVita Inc. | 83% |
For institutional investors. Book with your work email.
VirTech Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 1, 2022 | ||||
| Seed | Nov 1, 2022 | ||||
| Grant | Aug 1, 2021 |
For institutional investors. Book with your work email.
VirTech Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Army Medical Research and Development Command | Grant |
| Securitas Biosciences Group | Seed |
| Medical Technology Enterprise Consortium | Grant |
| U.S. Special Operations Command | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 114% MoM.
- May 1, 2025
Monthly visitors increased 120% MoM, reaching 1.3K.
For institutional investors. Book with your work email.
VirTech Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VirTech Bio's valuation, stock price, and market status.
Is VirTech Bio a public or private company?
VirTech Bio is a private company.
What is the current stock price of VirTech Bio?
VirTech Bio is a private company, so its shares have no public market price. Caplight tracks VirTech Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VirTech Bio worth (valuation)?
Valuation information for VirTech Bio is not publicly available.
Can I buy VirTech Bio stock?
VirTech Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VirTech Bio's last funding round?
VirTech Bio's most recent funding round was VC Round on December 1, 2022.
Who are the main investors in VirTech Bio?
Key investors in VirTech Bio include U.S. Army Medical Research and Development Command, U.S. Special Operations Command.
Will VirTech Bio IPO soon?
No public IPO plans have been announced for VirTech Bio.
How can I track VirTech Bio secondary market activity?
Caplight tracks bids, offers, and trades in VirTech Bio's shares on secondary markets.